
What is West Pharmaceutical Services'(WST) stock price?
Find the latest West Pharmaceutical Services, Inc. (WST) stock quote, history, news and other vital information to help you with your stock trading and investing.
Is WST stock a buy or sell?
WST | Complete West Pharmaceutical Services Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
What is the upside for West Pharmaceutical services (WTC) stock?
Apr 02, 2022 · West Pharmaceutical Services' stock was trading at $147.83 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, WST shares have increased by 157.9% and is now trading at $381.22. View which stocks have been most impacted by COVID-19.
Who owns westwest pharmaceutical services (west)?
Real time West Pharmaceutical Services (WST) stock price quote, stock graph, news & analysis.

Is West Pharmaceutical Services a buy right now?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last twelve months. There are currentl...
How has West Pharmaceutical Services' stock been impacted by Coronavirus (COVID-19)?
West Pharmaceutical Services' stock was trading at $147.83 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the...
Are investors shorting West Pharmaceutical Services?
West Pharmaceutical Services saw a increase in short interest in January. As of January 31st, there was short interest totaling 1,190,000 shares, a...
When is West Pharmaceutical Services' next earnings date?
West Pharmaceutical Services is scheduled to release its next quarterly earnings announcement on Thursday, May 5th 2022. View our earnings forecas...
How were West Pharmaceutical Services' earnings last quarter?
West Pharmaceutical Services, Inc. (NYSE:WST) released its quarterly earnings results on Thursday, February, 17th. The medical instruments supplier...
How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?
West Pharmaceutical Services declared a quarterly dividend on Wednesday, February 23rd. Shareholders of record on Wednesday, April 20th will be pai...
Is West Pharmaceutical Services a good dividend stock?
West Pharmaceutical Services pays an annual dividend of $0.72 per share and currently has a dividend yield of 0.20%. West Pharmaceutical Services h...
What guidance has West Pharmaceutical Services issued on next quarter's earnings?
West Pharmaceutical Services issued an update on its FY 2022 earnings guidance on Thursday, March, 10th. The company provided earnings per share gu...
What price target have analysts set for WST?
2 analysts have issued 1 year target prices for West Pharmaceutical Services' shares. Their forecasts range from $475.00 to $475.00. On average, th...
About West Pharmaceutical Services
West Pharmaceutical Services (NYSE:WST) Frequently Asked Questions
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products.
New York Stock Exchange
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last twelve months. There are currently 2 buy ratings for the stock.
News & Analysis: West Pharmaceutical Services
The Company is a manufacturer of components and systems for injectable drug delivery and plastic packaging and delivery system components for the healthcare, personal care and consumer products markets.
Environmental, Social, and Governance Rating
The Fool has written over 100 articles on West Pharmaceutical Services.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
What does WST stand for?
The Company is a manufacturer of components and systems for injectable drug delivery and plastic packaging and delivery system components for the healthcare, personal care and consumer products markets.
What is West Pharmaceutical Services?
Setup could also be viewed as a cup and "high" handle. Either way, worth watching. West Pharmaceutical Svcs (WST)- DEVELOPS COMPONENTS AND SYSTEMS FOR INJECTABLE DRUG DELIVERY AND PACKAGING FOR HEALTHCARE/CONSUMER PRODUCTS.
About WST
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
Analyst Forecast
West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products.
News
According to 7 analysts, the average rating for WST stock is "Buy." The 12-month stock price forecast is 457.00, which is an increase of 23.68% from the latest price.
West Pharmaceutical Services (NYSE:WST) Price Target and Consensus Rating
West Pharmaceutical's (WST) fourth-quarter earnings reflect strength in the Proprietary Products segment and margin expansion.
Analyst Price Target Consensus
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).
Analyst Ratings By Month
Sign-up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter.
Average Share Price and Price Target by Month
The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
West Pharmaceutical Services (NYSE:WST) Analyst Ratings Frequently Asked Questions
The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target.
Component Grades
According to the issued ratings of 2 analysts in the last year, the consensus rating for West Pharmaceutical Services stock is Buy based on the current 2 buy ratings for WST. The average twelve-month price target for West Pharmaceutical Services is $475.00 with a high price target of $475.00 and a low price target of $475.00.
WST POWR Grades
We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now.
WST Valuation Summary
WST scores best on the Quality dimension, with a Quality rank ahead of 77.52% of US stocks.
WST's Quality Factors
In comparison to the median Healthcare stock, WST's price/sales ratio is 16.3% higher, now standing at 13.2.
Latest WST News From Around the Web
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
Continue Researching WST
Below are the latest news stories about West Pharmaceutical Services Inc that investors may wish to consider to help them evaluate WST as an investment opportunity.
